Mark Joseph Ricciardi, MD
Director of Interventional Cardiology and Structural Heart Disease, Clinical and Research Programs
Expertise in aortic (TAVR), mitral (TMVR, MitraClip), tricuspid commercial and investigational device therapies as well as complex coronary intervention (PCI) and chronic total occlusion (CTO) interventions.
Related Videos
Transcatheter Mitral Valve-in-Valve Implantation for Failing Surgical Mitral Prosthesis
Mark Ricciardi, MD, performs the procedure on a patient with issues with previous mitral repair, lung disease and many pre-existing conditions.
NorthShore's Leading Interventional and Structural Heart Programs
Mark Ricciardi, MD, introduces NorthShore's Interventional and Structural Heart programs and gives the differences between the two.
NorthShore: Industry Leader in Transcatheter Therapies for Heart Disease
Mark Ricciardi, MD, gives an overview of NorthShore contributions to evolution of interventional cardiology and structural heart management.
Leading Interventional Procedures Offered at NorthShore
Mark Ricciardi, MD, gives an overview of NorthShore's most common minimally invasive procedures.
The NorthShore Advantage: Comprehensive Care From Industry Leaders
Mark Ricciardi, MD, describes the advantages of a comprehensive system like NorthShore University HealthSystem.
Innovative Clinical Trials and Cutting Edge Research at NorthShore Cardiovascular Institute
Mark Ricciardi, MD, discusses clinical trials and an experienced research team, researching the most innovative treatment for interventional and structural heart issues.
Is TAVR Right for Your Patient?
Mark Ricciardi, MD, describes the ideal patients for TAVR and other minimally invasive procedures.
History of Innovation at NorthShore
Mark Ricciardi, MD, discusses the history of innovation at NorthShore; access to leading edge clinical trials and cutting edge research.